Retrograde pedal access is a technique utilized with increasing frequency by many interventionists to address patients with advanced multilevel peripheral artery disease and significant comorbidities. This approach to revascularization is being used both in patients who fail traditional antegrade access and in some patients thought to be poor candidates for antegrade approach. However, the lack of randomized controlled trial data, or long-term results, coupled with the associated potential risks including dissection, spasm, and thrombosis have rendered retrograde pedal access a controversial topic. This article details the pros and cons associated with the debate surrounding retrograde pedal access and highlights the current literature and remaining questions regarding outcomes of this technique.
Introduction
Twenty-eight years ago, Dr Iyer and colleagues 1 first described a retrograde pedal technique using a posterior tibial cutdown to facilitate the endovascular revascularization of occluded tibial arteries in 2 patients who had failed conventional antegrade crossing techniques. 1 Today, over 2 decades later, retrograde pedal access is a technique utilized with increasing frequency by many interventionists to address patients with advanced multilevel peripheral artery disease and significant comorbidities. This approach to revascularization is being used both in patients who fail traditional antegrade access and in some patients thought to be poor candidates for antegrade approach. However, the lack of randomized controlled trial data, or longterm results, coupled with the associated potential risks including dissection, spasm, and thrombosis have rendered retrograde pedal access a controversial topic. This article details the pros and cons associated with the debate surrounding retrograde pedal access and highlights the current literature and remaining questions regarding the outcomes of this technique.
Pros
The primary argument for retrograde pedal access is to facilitate the endovascular management of high-risk critical limb ischemia patients with infrainguinal or infrapopliteal chronic total occlusions (CTOs). The goal is to avoid traditional open bypass and the associated rates of major morbidity/mortality which can be significant. An analysis of the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial, which randomized patients to either open bypass first or angioplasty for infra-inguinal lesions, reported that short-term clinical outcomes were similar in both groups, but that surgery was both significantly more morbid and expensive. Interestingly, the BASIL trial reported that more patients were alive in the open bypass group 2 years out from intervention, but this finding was based on a post hoc analysis with relatively small numbers.
Since the BASIL trial results, there has been significant advancement and adoption of percutaneous, endovascularfirst approaches to patients with critical limb ischemia (CLI). Technical success in a meta-analysis of studies using endovascular-first treatment modality noted the 3-year limb salvage rate to be 82.4% which is similar to open surgical results of 82.3%. 3, 4 Hence, attempts to cross lesions endovascularly by any means necessary may prove to be a useful option for patients versus moving directly to open surgical bypass.
That being said, up to 20% of tibial lesions cannot be crossed with the traditional antegrade techniques. 5, 6 In this patient cohort with classic CLI comorbidities that substantially increase open surgical risk, a retrograde pedal approach is a popular treatment option. There are several theories as to why the retrograde approach may result in a favorable crossing of an occlusion (1) potentially a more favorable cap may be encountered on the distal aspect of an occluded vessel either in shape (such as an upward curve) or in texture with less fibrotic or calcified tissue allowing easier passage, (2) less engagement of the collaterals allowing a straighter path through the occlusion, (3) the fact that another attempt from a different approach is being made adding to the potential for success. Although not well studied, when a subintimal approach is taken antegrade and difficulty is encountered to reenter the true lumen, the retrograde approach in conjunction along with ballooning could facilitate true lumen reentry. Ultimately, the goal is to increase the chance of successfully crossing the occlusion in endovascular fashion and avoiding the morbidity and mortality of open revascularization for these high-risk patients with CLI. This is possible using retrograde techniques in up to 86% to 100% of patients. [7] [8] [9] Although literature that has reported on outcomes of retrograde access has been supportive of the technique, the majority of these data have been reported in small case series or even single case reports with minimal follow-up. To date, no randomized controlled trials or even prospective trials comparing open to retrograde access revascularization have been reported. In 2003, Botti and colleagues 8 detailed 6 cases of patients with CLI who had failed traditional antegrade approaches and were successfully revascularized via the posterior tibial artery. However, 1 patient did require an amputation 3 months postprocedure for progressive foot infection. 8 In 2008, Montero-Baker and colleagues 9 described outcomes in 51 patients who had all failed antegrade access with 44 (86.3%) successfully achieving recanalization via the anterior tibial or posterior tibial artery. 9 One patient had thrombosis of the dorsalis pedis artery after an unsuccessful access and underwent in situ pedal bypass a day later. In 2010, Walker et al. 10 concluded that there was a decreased rate of amputation in patients who underwent pedal access revascularization especially in patients who presented with gangrene and reported a technical success rate of 93% in the 273 patients enrolled in the study. 10 Some of the strongest data, to date, supporting retro-pedal access comes from the prospective, nonrandomized, multicenter, observational study reviewing the safety and efficacy of tibiopedal access and retrograde crossing in the treatment of infra-inguinal CTOs. 7 Globally, 12 sites (8 United States and 3 European) enrolled 197 patients over a 1-year period. Patients were included if they had least 1 CTO for which a retrograde crossing procedure was planned or became necessary. The study had a significant percentage (32.5%) of patients who were claudicants (Rutherford categories 2 or 3) and 67.5% were patients with CLI (Rutherford category 4). Failure of antegrade approach was not mandated prior to utilization of retrograde access, although the majority (67%) of patients had a prior attempt at antegrade crossing. 7 Techniques used for access, retrograde lesion crossing, and treatment were at the operator's discretion. Patients were followed up for 30 days postprocedure, and technical tibiopedal access success was achieved in 93.4% patients (96.9% of claudicants and 91.7% of patients with CLI) and technical occlusion crossing success occurred in 85.3% (83.9% of claudicant patients and 86.1% of patients with CLI). The access success rate was 92.4% after a failed antegrade access versus 95.4% in those with a primary tibiopedal attempt which was not different statistically. There were no reported cases of patients that had access vessel thrombosis, compartment syndrome, or surgical revascularization. The authors concluded that tibiopedal access was effective and safe. 11 
Cons
Theoretically retrograde pedal access can have significant morbidity. Tibial vessels are small and, not infrequently, may be too small to allow for adequate micropuncture access. Known severe arterial spasm is encountered during wire and sheath placement which may necessitate the need for vasodilators such as nitroglycerine or papaverine to proceed with a procedure. In patients with cardiac comorbidity, this may be considered dangerous and increase the morbidity risk. Even more importantly, there is a theoretical risk of vessel thrombosis due to pedal access. In patients with tenuous distal vessel run-off, this may prove to be a complication that renders the limb unsalvageable.
From an operator standpoint, the technique itself is not without difficulties and complications. It has a definite learning curve, and the proximity to the limb during this access can subject the surgeon to more radiation exposure. 6 Tibial vessel calcification can vary, and this calcification may be the most important factor causing failed recanalization via a retropedal approach. Because the vessels are so small, placement of a sheath can be tricky and could result in occlusion and thrombosis and wire manipulation can, as always, potentially lead to dissection of a vessel and ultimately render it no longer an option for distal bypass. This is the primary concern when performing retropedal access and one of the main arguments against the procedure, particularly for claudicants or patients with single vessel runoff. The possibility of arterial disruption with resultant thrombosis at the access site has been reported in the literature and has a devastating impact especially in those patients with single vessel runoff. The reported rate of this complication, however, is very low. 9 A variety of techniques are utilized to minimize injury to the puncture site namely reducing the size of the access sheath or even avoiding the use of a sheath altogether. The current Cook Medical Micropuncture Pedal Access Set has a 4F introducer with a 2.9F inner diameter that allows passage of 0.018-or 0.014-in catheters or balloons as adjunctive tools for crossing the tibial occlusion. Walker et al 7 in their prospective, observation trial did note both minor and major complications of pedal access: Namely, 2% had local pain, 1% developed a site infection, 1% had ecchymosis, 1% had bleeding, and 0.5% had acute vessel dissection. The amputation rate at 30 days postprocedure was 6.1% in their study. 7 They reported no cases of thrombosis of the pedal vessel. However, Montero-Baker et al 9 did report 1 case of 44 that required subsequent bypass. Although the concern for vessel thrombosis is legitimate, the rate appears to be low at least in the case series published. To date, no studies have looked at the impact of retrograde access on future bypass targets or difficulty/complications of subsequent bypass.
Long-term outcomes of retropedal access with endovascular revascularization remain unknown. The follow-up data in the prospective, observation study by Walker and colleagues were only 30 days. 7 Most of the case reports and case series have average follow-up of 14 to 18 months. 8, 11 Bazan et al11 reviewed their experience with retropedal access in 13 patients who had lesions that could not be crossed in an antegrade fashion. They followed up patients for a mean of 17 + 10.3 months and reported the limb salvage rate to be 77%. Of the 4 technical failures, there were 3 patients with tissue loss and 1 with rest pain. Two of the 3 other technical failures with tissue loss later required below-knee amputation and 1 with ischemic rest pain underwent a popliteal-to-tibial bypass for symptom resolution. 11 The last patient had conservative management for a wound. Goltz et al12 reported similar outcomes at 1 year of 72.9 % for limb salvage. 12 Overall, retrograde pedal bypass has risks including arterial thrombosis, dissection, spasm, and infection; however, these complications are reported at low rates in the current literature. The primary limitation of this technique is the woeful lack of long-term data primarily in terms of wound healing and limb salvage. Results from best endovascular versus best surgical therapy in patients with critical limb ischemia 13 will likely add to our understanding of this technique.
Conclusion
Based on data from large case series and one prospective, observational trial, retrograde pedal access appears to be a safe, viable option increasing the odds of successful endovascular revascularization for patients with CLI. Although there are associated complications including thrombosis of a distal artery or arterial dissection, these risks seem to be relatively rare based on current reports. The long-term results of this technique, the use of this technique as a primary approach, the use of this technique in claudicants, and the impact of this technique in patients who ultimately require open bypass are areas where there remains a paucity of data and should be studied further. Ultimately, in skilled hands, this technique appears to be safe and beneficial in improving the chances of endovascular revascularization in patients with CLI.
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